ClinicalTrials.Veeva

Menu

Effects of Articaine Computer-controlled and Conventional Delivery for Anterior and Middle Superior Alveolar Nerve Block for Tooth Extraction

U

University of Belgrade

Status and phase

Withdrawn
Phase 4

Conditions

Local Anesthesia

Treatments

Drug: Computer controlled 4% articaine delivery by Anaeject
Drug: Conventional 4% articaine delivery by carpule syringe

Study type

Interventional

Funder types

Other

Identifiers

NCT03225326
UBelgrade 784/2

Details and patient eligibility

About

The purpose of this study was to investigate and compare pulpal anesthesia and cardiovascular parameters obtained with 0.6 ml of 4% articaine with epinephrine (1:100.000) for anterior and middle superior alveolar nerve (AMSA) block performed by standard and computer-controlled delivery for maxillary teeth extraction.

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • ASA 1
  • maxillary incisors canines or premolars indicated for extraction due to periapical pathology, root fracture or orthodontic treatment

Exclusion criteria

  • allergies to local anesthetic solution ingredients, food and drugs
  • alcohol and drugs abuse
  • heavy tobacco smoking

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

0 participants in 2 patient groups

Computer controlled 4% articaine delivery by Anaeject
Experimental group
Treatment:
Drug: Computer controlled 4% articaine delivery by Anaeject
Conventional 4% articaine delivery by carpule syringe
Active Comparator group
Treatment:
Drug: Conventional 4% articaine delivery by carpule syringe

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems